Company: BLLN
Filing Date: 2025-08-11
Form Type: DRS/A
Source: 0000950123-25-007483
Chunk: 354

Company: BillionToOne, Inc.
Filing Date: 2025-08-11
Form: DRS/A
Chunk 354
---
2024 |
|:--------------------------------------------------|:----|:--|------:|:--|:----|:--|------:|
| Unrecognized tax benefits - beginning of period   |     | $ |   818 |   |     | $ | 1,410 |
| Increases related to current year’s tax positions |     |   |   629 |   |     |   |   774 |
| Decreases related to prior years’ tax positions   |     |   |   (37 | ) |     |   |     - |
| Unrecognized tax benefits - end of period         |     | $ | 1,410 |   |     | $ | 2,184 |

The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. During the year ended December 31, 2023 and 2024, the Company recognized no interest and penalties associated with unrecognized tax benefits. There are no tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date. Due to the net operating loss carryforwards, all years remain open for income tax examination by tax authorities in the United States, various states and foreign tax jurisdictions in which the Company files tax returns.

| (13) | Employee Benefit Plan |

The Company sponsors a qualified 401(k) defined contribution plan covering eligible employees. Participants may contribute a portion of their annual compensation limited to a maximum annual amount set by the Internal Revenue Service. Employer contributions to the plan are discretionary. During the year ended December 31, 2023 and 2024, the Company contributed $1.7 million and $2.4 million to this plan, respectively.

| (14) | Related Party Transactions |

During the year ended December 31, 2023, the Company’s former CFO left the Company. Upon his departure, the Company’s Board of Directors approved the extension of the exercise period to ten years from the date of grant for all of his common stock options that were fully vested at the time of his departure. The impact on the financial statements resulting from the extension of the exercise term was not material. In February 2024, the Company also repurchased 26,750 shares of common stock that were held by the former CFO. Please refer to Note 11 for additional information on this transaction. There were no other material related party transactions during the year ended December 31,